Food As Medicine – The Future of Food
26 Sep 2024
Za'abeel Hall 3
Blockbuster GLP-Agonist drugs targeting obesity and diabetes are reshaping the world of diabetes and obesity treatments. The exuberant cost, inability to meet demand, unfavourable side effects, and lack of long-term impact data are creating unprecedented new opportunities for the food industry. The new Food-As-Medicine category is a multi-billion-dollar market opportunity.
This spotlight session will discuss the challenges and opportunities in this new category
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)
